Session » Abstracts: SLE – Diagnosis, Manifestations, & Outcomes III: Disease Activity
-
Abstract Number: 2551
Remission and Low Disease Activity (LDA) in Patients with SLE Treated with Belimumab (BEL): Results from a Large Integrated Analysis
-
Abstract Number: 2552
Inflammatory Fibrosis Precedes Loss of Kidney Function in Lupus Nephritis
-
Abstract Number: 2553
Prevalence, Determinants and Outcomes of Target Attainment in SLE Patients with Clinically Active Disease in a Large Multinational Prospective Lupus Cohort
-
Abstract Number: 2554
Validation of a Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus Erythematosus in a Confirmatory Cohort